Advertisement
Screener

ENTERA BIO LTD. (ENTX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ENTERA BIO LTD. Cash Flow Breakdown

Cash flow breakdown shows where ENTERA BIO LTD.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $7.37M went out.
  • Fiscal year ended 2025-12-31: from investing, $107.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $13.71M came in.
  • Fiscal year ended 2025-12-31: change in cash, $6.20M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$7.37M-$107.00K$6.25M$7.46M*$6.20M
2024-12-31-$6.82M-$3.00K$3.96M$516.00K*-$2.35M
2023-12-31-$7.31M-$17.00K$5.00K$6.03M*-$1.29M
2022-12-31-$12.50M-$102.00K$0.00-$12.59M
2021-12-31-$9.06M-$17.00K$21.80M$3.58M*$16.30M
2020-12-31-$10.56M-$53.00K$3.19M$864.00K*-$6.56M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$3.46M*-$3.00K*$0.00*$9.96M*
2026-03-31-$3.09M$0.00$0.00-$2.96M
2025-12-31-$1.83M*-$27.00K*$0.00*
2025-09-30-$2.50M*-$43.00K*$71.00K*
2025-06-30-$1.63M*-$29.00K*$0.00*
2025-03-31-$1.40M-$8.00K$6.18M$7.15M*$11.93M
2024-12-31-$1.47M*-$3.00K*$3.34M*
2024-09-30-$2.15M*$0.00*$0.00*
2024-06-30-$1.33M*$0.00*$620.00K*$596.00K*
2024-03-31-$1.86M$0.00$0.00-$1.83M
2023-12-31-$2.62M*-$5.00K*$0.00*$6.03M*
2023-09-30-$1.52M*$0.00*$0.00*
2023-06-30-$1.56M*-$1.00K*
2023-03-31-$1.61M-$11.00K-$1.62M
2022-12-31-$2.01M*-$3.00K*$0.00*
2022-09-30-$2.87M*-$57.00K*$0.00*
2022-06-30-$2.83M*-$19.00K*$0.00*
2022-03-31-$4.79M-$23.00K$0.00-$4.82M
2021-12-31-$2.51M*-$10.00K*$0.00*
2021-09-30-$2.11M*-$7.00K*$2.46M*
2021-06-30-$2.12M*$0.00*$9.48M*$3.18M*
2021-03-31-$2.32M$0.00$9.86M$7.79M

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33